Brief: Ono Pharmaceutical Enters Drug Discovery Collaboration & Option Agreement With Shattuck Labs
14/02/2024 10:32
Feb 14 (Reuters) - Ono Pharmaceutical 4528.T
* ONO ENTERS INTO A DRUG DISCOVERY COLLABORATION AND OPTION
AGREEMENT WITH SHATTUCK LABS TO GENERATE BIFUNCTIONAL FUSION
PROTEINS
* ONO PHARMACEUTICAL: WILL PAY TO SHATTUCK A TOTAL OF $227
MILLION, AS WELL AS TIERED ROYALTIES BASED ON NET SALES
Source text for Eikon: ID:nPnbmksdqa
Further company coverage: STTK.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shattuck Labs
See all newsBrief: Shattuck Labs Announces Phase 2 Clinical Trial Of Sl-325 In Hidradenitis Suppurativa And Appointment Of Shoba Ravichandran, M.D., As Senior Vice President, Clinical Development
Shattuck Labs Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health